Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Merit Medical Systems | 24 | 0 | 3 | 0 | €87.00 | €90.63 | 4.177% |
| Molina Healthcare | 17 | 1 | 2 | 0 | €301.20 | €368.16 | 22.231% |
| MorphoSys AG | 6 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €24.60 | - | - |
| Myriad Genetics | 4 | 3 | 0 | 0 | €23.80 | €22.15 | -6.944% |
| Nektar Therapeutics | 5 | 1 | 1 | 0 | €1.20 | €2.99 | 149.525% |
| Newron Pharmaceut. | 3 | 0 | 2 | 0 | €8.26 | - | - |
| Novartis AG ADR | 4 | 0 | 1 | 0 | €104.00 | €112.40 | 8.074% |
| Novavax Inc. | 6 | 1 | 1 | 0 | €12.40 | €21.98 | 77.162% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |
| Novo Nordisk A/S ADR | 25 | 1 | 4 | 0 | €105.00 | €144.48 | 37.600% |
| Ocular Therapeutix Inc. | 13 | 4 | 0 | 0 | €8.95 | €13.09 | 46.256% |
| Omeros Corp. | 2 | 2 | 0 | 0 | €3.49 | - | - |
| Omnicell Inc. | 3 | 1 | 0 | 0 | €37.40 | €35.34 | -5.508% |
| Pacira Pharmaceuticals | 22 | 1 | 1 | 0 | €14.10 | €40.02 | 183.830% |
| Paul Hartmann AG | 4 | 0 | 0 | 0 | €197.00 | - | - |
| Personalis Inc | 11 | 1 | 1 | 0 | €4.72 | €7.29 | 54.335% |
| Pfizer Inc. | 29 | 4 | 5 | 0 | €26.04 | €40.64 | 56.078% |
| Phibro Animal Health Corp. A | 1 | 3 | 0 | 0 | €19.50 | €12.06 | -38.133% |
| Polynovo Ltd | 1 | 0 | 0 | 0 | €1.54 | - | - |
| Precision BioSciences Inc | 8 | 0 | 0 | 0 | €0.35 | €35.86 | 10204.253% |
| Pro-Dex Inc. | 12 | 0 | 2 | 0 | €27.40 | €27.17 | -0.836% |
| ProQR Therapeutics N.V. | 7 | 2 | 0 | 0 | €1.58 | €2.32 | 46.515% |
| Prothena Corp. plc | 15 | 0 | 2 | 0 | €15.40 | €77.94 | 406.073% |
| PTC Therapeutics Inc. | 17 | 6 | 1 | 0 | €31.00 | €41.81 | 34.878% |